Data from Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy

Gaoyang Wang,Zuozhong Xie,Juan Su,Meishan Chen,Yanhua Du,Qian Gao,Guanxiong Zhang,Hailun Zhang,Xiang Chen,Hong Liu,Leng Han,Youqiong Ye
DOI: https://doi.org/10.1158/0008-5472.c.6514209.v1
2023-01-01
Abstract:AbstractAlternative polyadenylation (APA) is an important posttranscriptional modification commonly involved in tumor development. However, the functional roles of APA in tumor immunity remain largely unknown. Here, we performed an in-depth analysis of the 3′UTR usage of protein-coding genes and tumor immune response in 10,303 tumor samples across 31 cancer types to develop the immune-related APA event (ImmAPA) score pipeline, an integrated algorithm to characterize the regulatory landscape of APA events in cancer immunity–related pathways. Tumor-specific ImmAPAs that strongly correlate with immune cell infiltration and immune checkpoint blockade (ICB) treatment–related biomarkers were identified. Among these ImmAPAs, the top-ranking COL1A1 3′UTR usage was strongly associated with worse prognosis and tumor immune evasion. Furthermore, a machine learning approach to construct an ICB-related ImmAPA score model predicted immunotherapy efficacy. Overall, the characterization of immune-related APA that corresponds to tumor progression and tumor immunity highlights the clinical utility of APA events as potential biomarkers in cancer immunotherapy.Significance:Elucidation of the landscape of immune-related alternative polyadenylation in cancer identifies alternative polyadenylation events that may play a role in immune modulation and immunotherapy efficacy.
What problem does this paper attempt to address?